Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × maribavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 17 obinutuzumab 11 venetoclax 10 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 ibrutinib 5 Exercise 5 Biopsy 5 fludarabine phosphate 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 loncastuximab tesirine 3 glofitamab 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Therapeutics 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07014319 2025-12-04

MALMBA

Seoul National University Hospital

Phase 2 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡